AMPK activation has beneficial effects in in vivo experimental lymphoma models [10] or breast cancer cells other than MCF-7 (SKBR-3 and 4T1, as shown here, or MDA-MB-231 [34]). This evidence concerns the gene PRKAA1 and breast cancer.